Пољска - Пољски - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

ferring gmbh - menotropinum (fsh i lh) - proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań - 150 iu fsh + 150 iu lh

Европска Унија - Пољски - EMA (European Medicines Agency)

eli lilly nederland b.v. - abemaciclib - nowotwory piersi - Środki przeciwnowotworowe - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Европска Унија - Пољски - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine, lamiwudyna, tenofowir disoproxil fumarate - infekcje hiv - leki przeciwwirusowe do leczenia zakażeń hiv, kombinacje - delstrigo jest wskazany w leczeniu osób dorosłych zakażonych hiv-1, bez przeszłych lub aktualnych dowodów opór klasy nnrti, lamiwudyną lub tenofowir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.

Европска Унија - Пољски - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine - infekcje hiv - Środki przeciwwirusowe do użytku ogólnoustrojowego - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.

Европска Унија - Пољски - EMA (European Medicines Agency)

astellas pharma europe b.v. - gilteritinib fumaran - białaczka, szpikowe, ostre - Środki przeciwnowotworowe - xospata jest wskazany w monoterapii w leczeniu dorosłych pacjentów z nawrotem lub oporną na leczenie ostrej białaczki szpikowej (aml) z mutacją flt3 w .

Европска Унија - Пољски - EMA (European Medicines Agency)

novartis ireland ltd - ofatumumab - stwardnienie rozsiane, Рецидивно-znika - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.

Европска Унија - Пољски - EMA (European Medicines Agency)

bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - inne leki na układ nerwowy - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.

Европска Унија - Пољски - EMA (European Medicines Agency)

astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - preparaty antyanemiczne - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).

Пољска - Пољски - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

us pharmacia sp. z o.o. - famotidinum + magnesii hydroxidum + calcii carbonas - tabletki do rozgryzania i żucia - 10 mg + 165 mg + 800 mg

Европска Унија - Пољски - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.